Cell & Gene Therapy

The World Vaccine Congress is an award-winning series of conferences and exhibitions that
have grown to become the largest and most established vaccine meetings of their kind across
the globe. Our credibility is shown through the prestigious scientific advisory board that spend
months of hard work creating a new and topical agenda, year on year.

We’re excited to be moving to Amsterdam to leverage the well-established life science
ecosystem. Amsterdam is home to numerous pharmaceutical and biotechnology companies
(Boehringer Ingelheim, MSD, Moderna), research institutions (University of Amsterdam,
Amsterdam UMC), government (EMA, RIVM, ZIN) and healthcare organizations that focus
on innovation in vaccines. The proximity of relevant stakeholders and key players will incite
meaningful networking, collaboration, and discussions.

Now in its 26th annual edition, the World Vaccine Congress Europe will continue to bring experts
from the whole value chain under one roof, where you get to meet decision makers and listen to
KOL’s in the areas that are most applicable for your business offering.

The World Vaccine & Immunotherapy Congress West Coast is part of an award-winning series of conferences and exhibitions that are continuously growing becoming the largest and most established vaccine meetings of its kind across the globe. Scientific Affairs • Immunotherapy • Influenza • Infectious Disease • R&D • Regulatory Affairs • Manufacturing • Immunology • Oncology • Vaccines • Clinical Development • Partnerships

Two-day in person meeting on the latest development in RNA formulation strategies, therapeutic discover, modalities, and delivery approaches. Bringing together leading companies inspiring discussions, knowledge sharing and focused networking.

The Scientific Program features a diverse range of scientific sessions organized into two concurrent themed tracks covering issues such as Novel In Vitro and In Silico Assays to Predict Human Safety, In Vivo and Ex vivo Case Studies For Safety, Debate on the “Value” of Primary Tissue and In Vivo Studies and are disease Models Relevant in Safety Pharmacology, Macro Molecules Science: Antibodies, Oligo, and Peptides, Translation Beyond FIH Exposure Response Models, Macro Molecules Science: Gene therapy, Cell Therapy, mRNA and PROTAC, Derisking and Risk Mitigation Strategies, Clinical Cardiology, and much more! This will ensure attendees can stay abreast of new content and developments in key areas of interest. 

With more than 6,500 toxicologists from all over the world expected to attend, opportunities for networking and finding new collaborators are abundant—from the Scientific Sessions and other daytime events through the evening receptions. Research organizations, government agencies, drug developers, regulatory authorities, academic institutions, laboratory and medical suppliers, or consultants are encouraged to exhibit at ToxExpo.

RAPS Convergence is the largest and most well-recognized annual gathering of regulatory professionals, scientists, and innovators in the world. Convergence brings together representatives from industry, global regulatory bodies, and research, academic and clinical organizations that are directly involved in managing the regulatory process and aligning science, regulation, and business strategy.

Advanced Therapies Week brings the global advanced therapies community together for the most important week for doing business in advanced therapies. Home to the largest marketplace for tools and tech, Advanced Therapies Week is dedicated to helping biotech progress on their commercialisation journey, as well as pushing the industry one step closer to delivering life changing treatments to patients. Advanced Therapies Week was created for knowledge sharing, relationship building and deal making; through the connections you create and the knowledge you share, you help advance the next pillar of medicine.

An intensive 2-day in person meeting that delves into the latest in vaccine research, platform technologies, analytics and vaccine development & a meeting place for experts working within cutting-edge vaccine research & development. From new and exciting to the latest in products & services, our event will bring together over 200 leading companies for engaging discussions, knowledge sharing and focused networking.

Uncover how companies are furthering their understanding of the tumour microenvironment through the latest technologies, including spatial imaging and novel biomarkers. Gain insights in emerging therapeutic opportunities through targeting the tumour microenvironment with immunooncology.

A dedicated 2-day meeting with a focus on spatial genomics technologies & techniques, data analysis and therapeutic applications. Designed specifically for the US market, we are bringing together spatial experts, researchers and scientists for participating in focused discussions, workshops and give presentations that mirror the current challenges and future opportunities of the spatial biology market.